JCB logo
Direct PCR from Finnzymes
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online June 23, 2008
doi:10.1083/jcb.200803094
The Journal of Cell Biology, Vol. 181, No. 7, 1211-1222
The Rockefeller University Press, 0021-9525 $30.00
© 2008 Watanabe et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2395K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Watanabe, N.
Right arrow Articles by Shattil, S. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watanabe, N.
Right arrow Articles by Shattil, S. J.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
*Substance via MeSH
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Article

Mechanisms and consequences of agonist-induced talin recruitment to platelet integrin {alpha}IIbβ3

Naohide Watanabe1, Laurent Bodin1, Manjula Pandey1, Matthias Krause2, Shaun Coughlin3,4, Vassiliki A. Boussiotis5,6, Mark H. Ginsberg1, and Sanford J. Shattil1

1 Department of Medicine, University of California, San Diego, La Jolla, CA 92093
2 Randall Division of Cell and Molecular Biophysics, King's College London, London SE1 1UL, England, UK
3 Cardiovascular Research Institute and 4 Department of Medicine, University of California, San Francisco, San Francisco, CA 94143
5 Division of Hematology and Oncology and 6 Transplantation Biology Research Center, Massachusetts General Hospital, Boston, MA 02115

Correspondence to Sanford J. Shattil: sshattil{at}ucsd.edu

Platelet aggregation requires agonist-induced {alpha}IIbβ3 activation, a process mediated by Rap1 and talin. To study mechanisms, we engineered {alpha}IIbβ3 Chinese hamster ovary (CHO) cells to conditionally express talin and protease-activated receptor (PAR) thrombin receptors. Human PAR1 or murine PAR4 stimulation activates {alpha}IIbβ3, which was measured with antibody PAC-1, indicating complete pathway reconstitution. Knockdown of Rap1–guanosine triphosphate–interacting adaptor molecule (RIAM), a Rap1 effector, blocks this response. In living cells, RIAM overexpression stimulates and RIAM knockdown blocks talin recruitment to {alpha}IIbβ3, which is monitored by bimolecular fluorescence complementation. Mutations in talin or β3 that disrupt their mutual interaction block both talin recruitment and {alpha}IIbβ3 activation. However, one talin mutant (L325R) is recruited to {alpha}IIbβ3 but cannot activate it. In platelets, RIAM localizes to filopodia and lamellipodia, and, in megakaryocytes, RIAM knockdown blocks PAR4-mediated {alpha}IIbβ3 activation. The RIAM-related protein lamellipodin promotes talin recruitment and {alpha}IIbβ3 activity in CHO cells but is not expressed in megakaryocytes or platelets. Thus, talin recruitment to {alpha}IIbβ3 by RIAM mediates agonist-induced {alpha}IIbβ3 activation, with implications for hemostasis and thrombosis.

Abbreviations used in this paper: BiFC, bimolecular fluorescence complementation; IRES, internal ribosomal entry site; PAR, protease-activated receptor; RIAM, Rap1-GTP–interacting adaptor molecule; shRNA, short hairpin RNA; VASP, vasodilator-stimulated phosphoprotein.

© 2008 Watanabe et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents